المؤلفون: Aleksandr Suvorov, Tomas Pika, Ruben Niesvizky, Antonio Palumbo, Nehal Mohamed, Thierry Facon, Douglas E. Joshua, Meletios A. Dimopoulos, Philippe Moreau, Vesselina Goranova-Marinova, Heinz Ludwig, Sanjay K. Aggarwal, Albert Oriol, Roman Hájek, Heidi H. Gillenwater, H. Goldschmidt, Laura Rosiñol, Shibao Feng, Katja Weisel, Gianluca Gaidano, W. J. Chng, Luděk Pour

المصدر: Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: Adult, Oncology, Cancer Research, medicine.medical_specialty, Population, Salvage therapy, Dexamethasone, Disease-Free Survival, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Multiple myeloma, Aged, Lenalidomide, Aged, 80 and over, Salvage Therapy, education.field_of_study, business.industry, Hematology, Middle Aged, medicine.disease, Carfilzomib, 3. Good health, Surgery, Treatment Outcome, Prior Therapy, chemistry, 030220 oncology & carcinogenesis, Original Article, Multiple Myeloma, business, Oligopeptides, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::699f25105680fe0f9a501ec835ea46dfTest
https://doi.org/10.1038/leu.2016.186Test

المؤلفون: Aleksandr Suvorov, Goranova-Marinova, Sanjay K. Aggarwal, Gianluca Gaidano, Douglas E. Joshua, Nehal Mohamed, W. J. Chng, H. Goldschmidt, Meletios A. Dimopoulos, Albert Oriol, Thierry Facon, Heinz Ludwig, Laura Rosiñol, Katja Weisel, Heidi H. Gillenwater, Shibao Feng, Philippe Moreau, Luděk Pour, Roman Hájek, Tomas Pika, Ruben Niesvizky, Antonio Palumbo

المصدر: Leukemia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Phases of clinical research, Gastroenterology, Dexamethasone, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Biomarkers, Tumor, Humans, Lenalidomide, Chromosome Aberrations, Salvage Therapy, business.industry, Hazard ratio, Remission Induction, Hematology, Pomalidomide, Prognosis, Carfilzomib, 3. Good health, Surgery, Thalidomide, Survival Rate, Oncology, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Cytogenetic Analysis, Female, Original Article, Neoplasm Grading, Neoplasm Recurrence, Local, business, Multiple Myeloma, Oligopeptides, 030215 immunology, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5085835f8dacb4137116949dc42fe6c3Test
https://pubmed.ncbi.nlm.nih.gov/28025582Test

المؤلفون: Francesca Gay, Stefania Oliva, Maria Teresa Petrucci, Concetta Conticello, Lucio Catalano, Paolo Corradini, Agostina Siniscalchi, Valeria Magarotto, Luděk Pour, Angelo Carella, Alessandra Malfitano, Daniela Petrò, Andrea Evangelista, Stefano Spada, Norbert Pescosta, Paola Omedè, Philip Campbell, Anna Marina Liberati, Massimo Offidani, Roberto Ria, Stefano Pulini, Francesca Patriarca, Roman Hajek, Andrew Spencer, Mario Boccadoro, Antonio Palumbo

المصدر: The Lancet. Oncology. 16(16)

مصطلحات موضوعية: Melphalan, Male, Time Factors, Kaplan-Meier Estimate, Gastroenterology, Dexamethasone, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, ELDERLY-PATIENTS, Lenalidomide, Multiple myeloma, Czech Republic, INDUCTION, Hematopoietic Stem Cell Transplantation, Middle Aged, Thalidomide, Treatment Outcome, Oncology, Italy, Chemotherapy, Adjuvant, DEXAMETHASONE COMBINATION, INITIAL TREATMENT, SURVIVAL, Disease Progression, Female, Multiple Myeloma, medicine.drug, medicine.medical_specialty, Cyclophosphamide, BORTEZOMIB, Transplantation, Autologous, Disease-Free Survival, Maintenance Chemotherapy, Internal medicine, medicine, Autologous transplantation, Humans, CONSOLIDATION THERAPY, Aged, Proportional Hazards Models, business.industry, Australia, STEM-CELL TRANSPLANTATION, medicine.disease, Surgery, Transplantation, Prednisone, business, THALIDOMIDE, MELPHALAN

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0991ff626070483234040dc7311cfe36Test
https://pubmed.ncbi.nlm.nih.gov/26596669Test